Methods for the treatment of post-traumatic stress disorder and traumatic brain injury with cannabinoids
AssigneesAnanda Scientific, Inc, Lyotropic Delivery Systems Ltd.
InventorsMark J. ROSENFELD, Sohail R. ZAIDI, Christopher B.G. MOORE
Life of this patent
Estimating the term…
Abstract
The present disclosure Disclosed herein are pharmaceutical compositions comprising cannabinoids (e.g., cannabidiol) and an active-ingredient-bioavailability-enhancing-lipidic (AIBEL) formulations useful for the treatment of Post-traumatic Stress Disorder and/or Traumatic Brain Injury. Also disclosed are methods of effectively treating or preventing PTSD and/or Traumatic Brain Injury with said pharmaceutical compositions, as well as methods of making and kits containing said compositions. Finally, methods of predicting a subject's probability of response and selecting subjects most likely to benefit from CBD based treatment are disclosed.
Claims38
(canceled)
A method of treating Post-traumatic Stress Disorder (PTSD) in a subject comprising orally administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising:
- at least one cannabinoid,
- at least one oil;
- at least one hydrophilic surfactant;
- at least one co-surfactant;
- and
- less than 1 wt % water;
- wherein the total daily dose of cannabinoid administered to the subject is at least 50 mg/day.
-7. (canceled)
-14. (canceled)
-18. (canceled)
(canceled)
-25. (canceled)
-32. (canceled)
-36. (canceled)
-42. (canceled)
-47. (canceled)
(canceled)
(canceled)
-69. (canceled)
-73. (canceled)
-81. (canceled)
Dependencies are inferred from the claim text.